Sun-Novo(SH:688621) Xin Lang Cai Jing·2025-11-11 06:30Group 1 - The core point of the news is that Sunshine Nuohua's stock price increased by 5.21% to 59.39 CNY per share, with a trading volume of 189 million CNY and a turnover rate of 2.92%, resulting in a total market capitalization of 6.652 billion CNY [1] - Sunshine Nuohua, established on March 9, 2009, and listed on June 21, 2021, is based in Beijing and specializes in the development of generic drugs, consistency evaluation, and innovative drug development, with its main business revenue derived from CRO services at 99.91% [1] Group 2 - From the perspective of major shareholders, Rongtong Fund's health industry flexible allocation mixed fund A/B (000727) reduced its holdings by 550,000 shares in the third quarter, now holding 2 million shares, which accounts for 1.79% of the circulating shares, with an estimated floating profit of approximately 5.88 million CNY [2] - The Rongtong health industry flexible allocation mixed fund A/B (000727) was established on December 25, 2014, with a latest scale of 1.816 billion CNY, achieving a year-to-date return of 14.86% and a one-year return of 3.66% [2] Group 3 - The fund manager of Rongtong health industry flexible allocation mixed fund A/B (000727) is Wan Minyuan, who has a cumulative tenure of 9 years and 80 days, with the fund's total asset scale at 5.957 billion CNY, achieving the best return of 139.91% and the worst return of -22.4% during his tenure [3] Group 4 - The Rongtong health industry flexible allocation mixed fund A/B (000727) has Sunshine Nuohua as its sixth-largest heavy stock, holding 2 million shares, which accounts for 5.44% of the fund's net value, with an estimated floating profit of approximately 5.88 million CNY [4]